Table: Green Peptide -2016/17 group results

BrightPath Biotherapeutics Co

12/05/2017 07:00

May 12 (Reuters)-  
          Green Peptide Co., Ltd.  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended        Year to        NEXT    
              Mar 31, 2017    Mar 31, 2016    Mar 31, 2018      YEAR      
                 LATEST         YEAR-AGO         COMPANY       COMPANY    
                 RESULTS         RESULTS        FORECAST     H1 FORECAST  
  Sales          529 mln                         280 mln                  
                                               (-47.1 pct)                
  Operating     loss 1.11                       loss 2.00                 
  Recurring     loss 1.12                       loss 2.00                 
  Net 
  Net           loss 1.11                       loss 2.00                 
  EPS        loss 32.74 yen                  loss 53.74 yen               
  Ann Div          NIL             NIL             NIL                    
  -Q2 Div          NIL             NIL             NIL                    
  -Q4 Div          NIL             NIL             NIL                    
   
  NOTE - Green Peptide Co., Ltd.. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T 
  ((Tokyo Headline News Desk +813 6441 1812))